Together with the SAMISS, a screen for neurocognitive disorder should be done on all patients commencing ARVs, those failing first-line treatments, and those who have been on ARVs for more than 2 years.
Following this, additional measures, together with an assessment of true case-ness using a semi-structured diagnostic interview (such as the MINI neuropsychiatric interview), should be done to establish the local diagnostic validity and utility of the SAMISS and IHDS.